General Information
Version
MSDS/Aza-AUS/DP-004
Revision date
2024-10-14
Product name
Azacitidine Accord Powder for Injection
CAS No.
320-67-2
Manufacturer Name
Accord Healthcare Pty Ltd
Icons in SDS
Company Information
company name
Accord Healthcare Pty Ltd
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H302, H341, H350, H360FD, H372, H400, H410
Hazard statements
Code
Statements
H302
Harmful if swallowed
H341
Suspected of causing genetic defects
H350
May cause cancer
H360FD
May damage fertility. May damage the unborn child.
H372
Causes damage to organs through prolonged or repeated exposure
H400
Very toxic to aquatic life
H410
Very toxic to aquatic life with long lasting effects
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Germ Cell Mutagenicity Category 2 Reproductive Toxicity Category 1B Carcinogenic Category 1B Acute toxicity - oral Category 4 Specific Target Organ Category 1 Toxicity (repeated exposure) - Aquatic toxicity (acute) Category 1 Aquatic toxicity (chronic) Category 1
Signal word
Danger
Hazard statements
H302 - Harmful if swallowed H341 - Suspected of causing genetic defects H350 - May cause cancer H360FD - May damage fertility. May damage the unborn child H372 - Causes damage to hematological and gastrointestinal systems through prolonged or repeated exposure H400 - Very toxic to aquatic life H410 - Very toxic to aquatic life with long-lasting effects
Precautionary statements
P201 - Obtain special instructions before use P202 - Do not handle until all safety precautions have been read and understood P260 - Do not breathe dust P264 - Wash hands thoroughly after handling P270 - Do not eat, drink or smoke when using this product P273 - Avoid release to the environment P280 - Wear protective gloves/eye protection/face protection. P281 - Use personal protective equipment as required P308 + P313 - IF exposed or concerned: Get medical attention/advice P301 + P312 - IF SWALLOWED: Call a Poison Center or doctor/physician if you feel unwell P330 - Rinse mouth P391 - Collect spillage P405 - Store locked up P501 - Dispose of contents/container in accordance with all local and national regulations
2.3 Other hazards
The most commonly occurring adverse effects with therapeutic use include hematological toxicity (e.g., thrombocytopenia, anemia, neutropenia), fever, gastrointestinal effects (e.g., nausea, vomiting, diarrhea, constipation), fatigue, injection site erythema, ecchymosis (skin discoloration caused by escape of blood into tissues from ruptured blood vessels). Other effects may include hypotension, shortness of breath, liver/kidney toxicity and electrolyte abnormalities. Post marketing reports of interstitial lung disease and tumor lysis syndrome may also be azacitidine-related. Note: This mixture is classified as hazardous under GHS as implemented by Regulation EC No